Pancreatic Cancer Research

ResearcherHerlev HospitalActive in the last 2 years

Simon Ezban Grützmeier

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3524-1133; OpenAlex author ID A5092502312. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

  1. EUS-guided biopsies versus surgical specimens for establishing patient-derived pancreatic cancer organoids: a systematic review and meta-analysis. Co-author DOI 10.1016/j.gie.2024.04.012↗
  2. Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer. Co-author DOI 10.3390/cancers15143677↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Peter Vilmann · 2 shared papers, 2023–2024 · strength 0.41
  2. Pia Helene Klausen · 2 shared papers, 2023–2024 · strength 0.41
  3. Bojan Kovacevic · 2 shared papers, 2023–2024 · strength 0.41
  4. Hanne Grossjohann · 1 shared paper, 2023 · strength 0.15
  5. Estrid Vilma Solyom Høgdall · 1 shared paper, 2023 · strength 0.15
  6. Carsten Palnæs Hansen · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.